CD44, as well as other CSC markers endoglin (CD105) and CD106 has been proved to be highly expressed in chemo-resistant ovarian cancer cells and in advanced-stage epithelial ovarian cancer tissues, suggesting CD44 may accelerate the progression of ovarian cancer by modulating the properties of CSCs (24). The gene discussed is ENG; the disease is ovarian carcinoma.